Erythropoietin Receptor Signaling through STAT3 Is Required for Glioma Stem Cell Maintenance

Recombinant erythropoietin (EPO) is a growth factor used in the treatment of chemotherapy-induced anemia, but recent studies suggest that EPO may accelerate cancer growth. Although several cancers express EPO receptors (EPORs), the mechanism by which EPOR promotes tumor growth remains poorly underst...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Cao, Yiting, Lathia, Justin D., Eyler, Christine E., Wu, Qiulian, Li, Zhizhong, Wang, Hui, McLendon, Roger E., Hjelmeland, Anita B., Rich, Jeremy N.
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2010
Matèries:
Original Articles and Short Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2906804/
https://ncbi.nlm.nih.gov/pubmed/20657792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1947601909356352
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars